Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EVE Health GroupASX:EVE Receivables Turnover is 15.44 as of Dec. 2025. The stock has 6 warning signs investors should review. Among 1,946 Consumer Packaged Goods companies, EVE Health Group ranks better than 54.21% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. EVE Health Group's Revenue for the
six
months ended in Dec. 2025 was A$0.63 Mil. EVE Health Group's average Accounts Receivable for the
six
months ended in Dec. 2025 was A$0.04 Mil.
Hence, EVE Health Group's Receivables Turnover for the
six
months ended in Dec. 2025 was 15.44.
EVE Health Group (ASX:EVE) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
EVE Health Group Receivables Turnover Related Terms
EVE Health Group Receivables Turnover Historical Data
* Premium members only.
The historical data trend for EVE Health Group's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:EVE vs KHC, GIS: Receivables Turnover Comparison
For the Packaged Foods subindustry, EVE Health Group's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EVE Health Group Receivables Turnover vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, EVE Health Group's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where EVE Health Group's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EVE Health Group (ASX:EVE) has a Receivables Turnover of 15.44 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on EVE Health Group and its competitors. According to the industry distribution chart, EVE Health Group ranks #891 out of 1946 companies in the Consumer Packaged Goods industry, placing it in the top 45.8%.
Is EVE Health Group's Receivables Turnover too high?
EVE Health Group's current Receivables Turnover is 15.44. The Consumer Packaged Goods industry median Receivables Turnover is 9.33. EVE Health Group's value of 15.44 is 65.5% above this industry median. Based on the distribution chart, EVE Health Group ranks #891 out of 1946 companies in the Consumer Packaged Goods industry, which is above the industry midpoint.
How does EVE Health Group's Receivables Turnover compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, EVE Health Group ranks #891 out of 1946 companies for Receivables Turnover. This puts EVE Health Group in the upper half of its industry. The industry median Receivables Turnover is 9.33. EVE Health Group's value of 15.44 is 65.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Consumer Packaged Goods company?
The median Receivables Turnover among Consumer Packaged Goods companies is 9.33, based on 1,946 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EVE Health Group's current Receivables Turnover of 15.44 is 65.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on EVE Health Group and its competitors. For the Consumer Packaged Goods industry, the median Receivables Turnover is 9.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EVE Health Group's current Receivables Turnover is 15.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EVE Health Group stock overvalued right now?
Based on GuruFocus' analysis, EVE Health Group (ASX:EVE) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.01, compared to a current price of A$0.02 — trading 70% above its estimated fair value. The current Receivables Turnover is 15.44 and 65.5% above the Consumer Packaged Goods industry median of 9.33. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For EVE Health Group (ASX:EVE), the current Receivables Turnover is 15.44 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
EVE Health Group Ltd is an integrated Health, Nutrition, and Wellness investment company. The company operates in two reporting segments, namely Meluka (branded wellness consumer products) and Nextract.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:EVE has been successfully added to your 
